0001497446-14-000003.txt : 20140620 0001497446-14-000003.hdr.sgml : 20140620 20140620144808 ACCESSION NUMBER: 0001497446-14-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140620 DATE AS OF CHANGE: 20140620 EFFECTIVENESS DATE: 20140620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GeneWeave Biosciences, Inc. CENTRAL INDEX KEY: 0001497446 IRS NUMBER: 272792087 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-219595 FILM NUMBER: 14932521 BUSINESS ADDRESS: STREET 1: 983 UNIVERSITY AVE., BUILDING B CITY: LOS GATOS STATE: CA ZIP: 95032 BUSINESS PHONE: 408 560-9200 MAIL ADDRESS: STREET 1: 983 UNIVERSITY AVE., BUILDING B CITY: LOS GATOS STATE: CA ZIP: 95032 D 1 primary_doc.xml X0707 D LIVE 0001497446 GeneWeave Biosciences, Inc. 983 UNIVERSITY AVE., BUILDING B LOS GATOS CA CALIFORNIA 95032 408 560-9200 DELAWARE None None Corporation true 2010 Steven Tablak c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Executive Officer Director Nora Bianchi c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Executive Officer Jason Springs c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Executive Officer Director Diego Rey c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Executive Officer Werner Frei c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Executive Officer Kenneth Bahk, Ph.D. c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Director Min Cui, Ph.D. c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Director Ted Driscoll, Ph.D. c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Director Biotechnology Decline to Disclose 06b false 2014-05-23 false true true Offering of Series B Preferred Stock and the underlying shares of Common Stock issuable upon conversion of the Series B Preferred Stock. false 0 11999998 11999998 0 false 4 0 0 0 false GeneWeave Biosciences, Inc. /s/ Steven Tablak Steven Tablak Chief Executive Officer 2014-06-11